US7170811035
US7170811035
Pfizer, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 161.19B EUR | 137.24B EUR | 160.03B EUR | 141.58B EUR |
Enterprise Value | 210.64B EUR | 199.46B EUR | 222.05B EUR | 204.4B EUR |
Valuation Multiples | ||||
Trailing P/E | 37.21x | 31.68x | 21.37x | 29.48x |
Forward P/E | 9.75x | -- | -- | -- |
Price to Sales | 2.53x | 2.15x | 2.53x | 2.9x |
Price to Book | 1.89x | 1.61x | 1.78x | 1.64x |
EV/Revenue | 3.31x | 3.13x | 3.51x | 4.18x |
EV/EBITDA | 8.3x | 7.83x | 8.68x | 10.53x |
Price to FCF (P/FCF) | 12.91x | 12.49x | 16.88x | 19.38x |
EV/FCF | 16.87x | 18.16x | 23.42x | 27.98x |
FCF Yield | 7.75% | 8% | 5.93% | 5.16% |